PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 8647969

Psychodermatology: an update.

M A Gupta·A K Gupta
View original source ↗Export metadata ↓

Abstract

It has been estimated that in at least one third of dermatology patients, effective management of the skin disorder involves consideration of associated emotional factors. This article provides an overview of psychodermatology with a focus on the more recent literature and an emphasis on the clinical aspects and psychologic therapies for (1) cutaneous associations of psychiatric disorders and (2) psychiatric associations of certain cutaneous disorders that are known to be influenced by psychosomatic factors. This article also provides an update on the use of psychotropic drugs (i.e., the antianxiety, antidepressant, and antipsychotic agents) for the treatment of mental disorders that occur in conjunction with cutaneous conditions. Some of their other pharmacologic properties, such as the antihistaminic and analgesic effects of some antidepressant agents are also reviewed.

Explore related subjects

AnalgesicsAnti-Anxiety AgentsAntidepressive AgentsAntipsychotic AgentsEmotionsHistamine H1 AntagonistsHumansMental DisordersPsychophysiologic DisordersPsychotherapyPsychotropic DrugsSkin DiseasesJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M A Gupta, A K Gupta. 1996. Psychodermatology: an update.. https://doi.org/10.1016/s0190-9622(96)90284-4

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1997

Differential modulation of NMDA-stimulated [3H]dopamine release from rat striatum by neuropeptide Y and sigma receptor ligands.

Although the identity of the endogenous ligands for sigma (sigma) receptors is unknown, neuropeptide Y (NPY) has been named as a possible candidate for a natural transmitter at these receptors. Using a superfusion system, we compared the effect of NPY on NMDA-stimulated [3H]dopamine release in rat striatum to that of the sigma agonists (+)-pentazocine and BD737. In contrast to (+)-pentazocine- or BD737-mediated inhibition of release, NPY enhanced release. However, the same sigma antagonists (BD1008, DuP734, haloperidol and DTG) that reverse (+)-pentazocine- or BD737-mediated inhibition, as well as a Y receptor antagonist, PYX-1, all reversed the enhancement. PYX-1 also reversed the (+)-pentazocine- and BD737-mediated inhibition of release. Peptide YY (PYY) and [Leu31,Pro34]NPY did not mimic the effect of NPY. NPY13-36 enhanced release to the same extent as NPY but the effect was not reversed by sigma antagonists. Our findings are consistent with the potential role of NPY as an endogenous ligand for a subtype of sigma receptor with characteristics different from Y1, Y2 and Y3 receptors but sensitive to PYX-1.

Analgesics↗
PubMed1997

Correlation between subjective and objective measures used to determine severity of postoperative pain in dogs.

OBJECTIVE: To determine the association between subjective and objective variables commonly used to evaluate severity of postoperative pain in dogs. DESIGN: Prospective double-blind study. ANIMALS: 36 dogs with unilateral rupture of the cranial cruciate ligament that underwent surgery to stabilize the stifle. PROCEDURE: Each dog was assessed to determine severity of pain before and after surgery, using various subjective and objective criteria. RESULTS: Subjective measures of pain (scores for visual analogue and numerical rating scales) correlated poorly or were not correlated with heart rate, respiratory rate, blood pressure, and results of a pain threshold test. Scores for visual analogue and numerical rating scales correlated with each other and with the amount of vocalization at most time periods. CLINICAL IMPLICATIONS: We detected a weak association between commonly employed subjective and objective measures of pain. This indicated that some of these measurement techniques do not predictably reflect severity of postoperative pain in dogs. Therefore, clinicians should not rely too heavily on these variables when assessing severity of postoperative pain in dogs.

Analgesics↗